Inhibikase Therapeutics, Inc. short interest in 2024
In 2024, Inhibikase Therapeutics, Inc.'s disclosed short interest ran from 1.00% of shares outstanding on 31 Jan 2024 to 1.28% on 31 Dec 2024, a change of +0.28 percentage points. The year's high was 1.38% on 15 Feb 2024 and its low 0.31% on 28 Mar 2024, averaging 0.75% across 15 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.85 days on 15 Aug 2024. Full history: Inhibikase Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 1.00% (31 Jan 2024)
- End of year
- 1.28% (31 Dec 2024)
- Change
- +0.28 pp
- High
- 1.38% (15 Feb 2024)
- Low
- 0.31% (28 Mar 2024)
- Average
- 0.75%
- Highest days to cover
- 3.85 (15 Aug 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Jan 2024 | 1.00% | 1.00 | |
| 15 Feb 2024 | 1.38% | 1.00 | |
| 29 Feb 2024 | 0.83% | 1.00 | |
| 15 Mar 2024 | 0.47% | 1.00 | |
| 28 Mar 2024 | 0.31% | 1.00 | 10-K filed |
| 15 Jul 2024 | 0.71% | 1.45 | 10-Q filed |
| 31 Jul 2024 | 0.94% | 2.03 | |
| 15 Aug 2024 | 0.73% | 3.85 | 10-Q filed |
| 30 Aug 2024 | 0.59% | 1.51 | |
| 13 Sep 2024 | 0.53% | 2.14 | |
| 30 Sep 2024 | 0.59% | 2.21 | |
| 15 Nov 2024 | 0.45% | 1.00 | 10-Q filed |
| 29 Nov 2024 | 0.43% | 1.59 | |
| 13 Dec 2024 | 1.00% | 2.29 | |
| 31 Dec 2024 | 1.28% | 1.52 |
See also: Inhibikase Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.